Morgan Stanley Qiagen N.V. Transaction History

Morgan Stanley

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$35.55 - $43.57 $233,101 - $285,688	6,557 Added 0.22%	3,036,382 $132 Million
Q3 2023 Nov 15, 2023	BUY	$39.13 - $47.24 $4.74 Million - $5.72 Million	121,155 Added 4.17%	3,029,825 $123 Million
Q2 2023 Aug 14, 2023	SELL	$43.93 - $46.76 $12.4 Million - $13.2 Million	-282,012 Reduced 8.84%	2,908,670 $131 Million
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $12.6 Million - $14.2 Million	279,155 Added 9.59%	3,190,682 $147 Million
Q4 2022 Feb 14, 2023	BUY	$41.91 - $50.48 $5.55 Million - $6.69 Million	132,479 Added 4.77%	2,911,527 $145 Million

Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $4.52 Million - $5.57 Million	110,431 Added 4.14%	2,779,048 $115 Million
Q2 2022 Oct 27, 2022	BUY	$42.98 - $49.77 $59.3 Million - $68.7 Million	1,379,386 Added 106.99%	2,668,617 $126 Million
Q2 2022 Aug 15, 2022	BUY	$42.98 - $49.77 $59.3 Million - $68.7 Million	1,379,386 Added 106.99%	2,668,617 $126 Million
Q1 2022 Oct 27, 2022	SELL	$42.23 - $54.3 $58.3 Million - $74.9 Million	-1,379,386 Reduced 51.69%	1,289,231 $63.2 Million
Q1 2022 May 13, 2022	BUY	$42.23 - $54.3 $5.14 Million - $6.61 Million	121,645 Added 10.42%	1,289,231 $63.2 Million
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $8.45 Million - $9.43 Million	-166,980 Reduced 12.51%	1,167,586 $64.9 Million
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $62.1 Million - $75.8 Million	1,334,566 New	1,334,566 $69 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.24B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.